The role of chloroplast electron transport and metabolites in modulating rubisco activity in tobacco. Insights from transgenic plants with reduced amounts of cytochrome b/f complex or glyceraldehyde 3-phosphate dehydrogenase
Sa. Ruuska et al., The role of chloroplast electron transport and metabolites in modulating rubisco activity in tobacco. Insights from transgenic plants with reduced amounts of cytochrome b/f complex or glyceraldehyde 3-phosphate dehydrogenase, PLANT PHYSL, 122(2), 2000, pp. 491-504
Leaf metabolites, adenylates, and Rubisco activation were studied in two tr
ansgenic tobacco (Nicotiana tabacum L. cv W38) types. Plants with reduced a
mounts of cytochrome b/f complex (anti-b/f) have impaired electron transpor
t and a low transthylakoid pH gradient that restrict ATP and NADPH synthesi
s. Plants with reduced glyceraldehyde 3-phosphate dehydrogenase (anti-GAPDH
) have a decreased capacity to use ATP and NADPH in carbon assimilation. Th
e activation of the chloroplast NADP-malate dehydrogenase decreased in anti
-b/f plants, indicating a low NADPH/ NADP(+) ratio. The whole-leaf ATP/ADP
in anti-b/f plants was similar to wild type, while it increased in anti-GAP
DH plants. In both plant types, the CO2 assimilation rates decreased with d
ecreasing ribulose 1,5-bisphosphate concentrations. In anti-b/f plants, CO2
assimilation was further compromised by reduced carbamylation of Rubisco,
whereas in anti-GAPDH plants the carbamylation remained high even at subsat
urating ribulose 1,5-bisphosphate concentrations. We propose that the low c
arbamylation in anti-b/f plants is due to reduced activity of Rubisco activ
ase. The results suggest that light modulation of activase is not directly
mediated via the electron transport rate or stromal ATP/ADP, but some other
manifestation of the balance between electron transport and the consumptio
n of its products. Possibilities include the transthylakoid pH gradient and
the reduction state of the acceptor side of photosystem I and/or the degre
e of reduction of the thioredoxin pathway.